Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 2.93 billion. The enterprise value is 2.69 billion.
Market Cap | 2.93B |
Enterprise Value | 2.69B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 79.07 million shares outstanding. The number of shares has decreased by -1.21% in one year.
Shares Outstanding | 79.07M |
Shares Change (YoY) | -1.21% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 50.31% |
Owned by Institutions (%) | 20.43% |
Float | 37.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.20 |
PB Ratio | 3.27 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -25.26 |
EV / Sales | 5.71 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -31.63 |
Financial Position
The company has a current ratio of 2.77
Current Ratio | 2.77 |
Quick Ratio | 2.65 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -540.39 |
Financial Efficiency
Return on equity (ROE) is -11.16% and return on invested capital (ROIC) is -7.27%.
Return on Equity (ROE) | -11.16% |
Return on Assets (ROA) | -6.37% |
Return on Capital (ROIC) | -7.27% |
Revenue Per Employee | 1.19M |
Profits Per Employee | -269,870 |
Employee Count | 395 |
Asset Turnover | 0.43 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.53% in the last 52 weeks. The beta is 0.51, so Nordhealth AS's price volatility has been lower than the market average.
Beta (5Y) | 0.51 |
52-Week Price Change | +53.53% |
50-Day Moving Average | 34.01 |
200-Day Moving Average | 29.01 |
Relative Strength Index (RSI) | 54.93 |
Average Volume (20 Days) | 23,334 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 471.77 million and -106.60 million in losses. Loss per share was -1.35.
Revenue | 471.77M |
Gross Profit | 139.40M |
Operating Income | -111.06M |
Pretax Income | -103.81M |
Net Income | -106.60M |
EBITDA | -47.02M |
EBIT | -111.06M |
Loss Per Share | -1.35 |
Balance Sheet
Cash & Cash Equivalents | 232.70M |
Total Debt | n/a |
Net Cash | 232.70M |
Net Cash Per Share | 2.94 |
Equity (Book Value) | 894.37M |
Book Value Per Share | 11.31 |
Working Capital | 210.37M |
Cash Flow
In the last 12 months, operating cash flow was -24.97 million and capital expenditures -60.16 million, giving a free cash flow of -85.13 million.
Operating Cash Flow | -24.97M |
Capital Expenditures | -60.16M |
Free Cash Flow | -85.13M |
FCF Per Share | -1.08 |
Margins
Gross margin is 29.55%, with operating and profit margins of -23.54% and -22.60%.
Gross Margin | 29.55% |
Operating Margin | -23.54% |
Pretax Margin | -22.00% |
Profit Margin | -22.60% |
EBITDA Margin | -9.97% |
EBIT Margin | -23.54% |
FCF Margin | -18.05% |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.21% |
Shareholder Yield | 1.21% |
Earnings Yield | -3.64% |
FCF Yield | -2.91% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |